The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical activity of BLU-285 in advanced gastrointestinal stromal tumor (GIST).
 
Michael C. Heinrich
Stock and Other Ownership Interests - MolecularMD
Honoraria - Novartis
Consulting or Advisory Role - ARIAD; Blueprint Medicines; MolecularMD; Novartis; Pfizer
Research Funding - ARIAD (Inst); Arog (Inst); Deciphera (Inst); Inhibikase (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patent on treatment of GIST-licensed to Novartis (Inst)
Expert Testimony - Novartis
 
Robin Lewis Jones
Consulting or Advisory Role - Adaptimmune; Daiichi Sankyo; Eisai; Immodulon Therapeutics; Immune Design; Lilly; Merck Serono; Morphotek; TRACON Pharma
Research Funding - GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Margaret von Mehren
Consulting or Advisory Role - Blueprint Medicines; CytRx Corporation; Eisai; Janssen Oncology
Research Funding - ArQule
Travel, Accommodations, Expenses - ARIAD; Blueprint Medicines; Eisai; Janssen Oncology; Novartis
 
Patrick Schoffski
Honoraria - Daiichi Sankyo; Eisai; Lilly; Medpace; Novartis; Swedish Orphan Biovitrum
Consulting or Advisory Role - 6th Element Capital (Inst); Adaptimmune (Inst); Amcure (Inst); AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Cristal Therapeutics (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Epizyme (Inst); Genzyme (Inst); Ipsen (Inst); Lilly (Inst); Loxo (Inst); Medpace (Inst); Nektar (Inst); Nektar (Inst); Novartis (Inst); Novartis (Inst); Philogen (Inst); Philogen (Inst); Pique (Inst); Pique (Inst); Plexxikon (Inst); Plexxikon (Inst)
Speakers' Bureau - Bayer; Eisai; GlaxoSmithKline; Lilly; Novartis; PharmaMar; Swedish Orphan Biovitrum
Research Funding - Bayer (Inst); Blueprint Medicines (Inst); CoBioRes NV (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - 6th Eement Capital; Adaptimmune; Amcure; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Cristal Therapeutics; Daiichi Sankyo; Eisai; Epizyme; Genzyme; GlaxoSmithKline; Ipsen; Lilly; Loxo; Medpace; Nektar; Novartis; PharmaMar; Philogen; Piqur; Plexxikon; Swedish Orphan Biovitrum
 
Sebastian Bauer
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer; Pharmamar
Consulting or Advisory Role - Bayer; Blueprint Medicines; Lilly; Mundipharma
Research Funding - Blueprint Medicines; Novartis
Travel, Accommodations, Expenses - Pharmamar
 
Olivier Mir
Stock and Other Ownership Interests - Netcancer
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Blueprint Medicines; Bristol-Myers Squibb; Eisai; Lilly; Novartis; Pfizer; Roche/Genentech; SERVIER
Speakers' Bureau - Lilly; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); Eisai (Inst); Lilly (Inst); Novartis (Inst); PharmaMar (Inst); Roche/Genentech (Inst)
 
Philippe Alexandre Cassier
Honoraria - Amgen; Blueprint Medicines; Novartis; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); Celgene (Inst); Lilly (Inst); Novartis (Inst); Plexxikon (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Amgen; Novartis; Roche
 
Ferry Eskens
No Relationships to Disclose
 
Hongliang Shi
Employment - Blueprint Medicines
Stock and Other Ownership Interests - Blueprint Medicines
 
Terri Alvarez-Diez
Employment - Blueprint Medicines
Stock and Other Ownership Interests - Blueprint Medicines
 
Oleg Schmidt-Kittler
Employment - Blueprint Medicines
Stock and Other Ownership Interests - Blueprint Medicines
 
Mary Ellen Healy
Employment - Blueprint Medicines
Stock and Other Ownership Interests - Blueprint Medicines
 
Beni B. Wolf
Employment - Blueprint Medicines
Stock and Other Ownership Interests - Blueprint Medicines
 
Suzanne George
Stock and Other Ownership Interests - Abbvie (I)
Consulting or Advisory Role - AstraZeneca
Research Funding - Bayer (Inst); Blueprint Medicines (Inst); Deciphera (Inst); Novartis (Inst); Pfizer (Inst)